부산대학교 도서관

McFaline-Figueroa, José L. ; Srivatsan, Sanjay ; Hill, Andrew J. ; Gasperini, Molly ; Jackson, Dana L. ; Saunders, Lauren ; Domcke, Silvia ; Regalado, Samuel G. ; Lazarchuck, Paul ; Alvarez, Sarai ; Monnat, Raymond J., Jr. ; Shendure, Jay ; Trapnell, Cole

In Cell Genomics 14 February 2024 4(2)

Suryadevara CM; Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY, United States.; Donaldson H; Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY, United States.; Khan HA; Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY, United States.; Groff KJ; Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY, United States.; Kim CD; Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY, United States.; Dogra S; Deparment of Radiology, NYU Grossman School of Medicine, New York, NY, United States.; Gautreaux J; Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY, United States.; Roberts LG; of Pathology, NYU Grossman School of Medicine, New York, NY, United States.; Young MG; Deparment of Radiology, NYU Grossman School of Medicine, New York, NY, United States.; Snuderl M; of Pathology, NYU Grossman School of Medicine, New York, NY, United States.; Zagzag D; of Pathology, NYU Grossman School of Medicine, New York, NY, United States.; William CM; of Pathology, NYU Grossman School of Medicine, New York, NY, United States.; McFaline-Figueroa JR; Department of Neurology, NYU Grossman School of Medicine, New York, NY, United States; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, United States; Perlmutter Cancer Center, NYU Langone Health, United States.; Pilar Guillermo Prieto Eibl MD; Department of Neurology, NYU Grossman School of Medicine, New York, NY, United States; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, United States; Perlmutter Cancer Center, NYU Langone Health, United States.; Cordova CA; Department of Neurology, Mayo Clinic, Jacksonville, FL, United States.; Kurz S; Department of Neurology, Yale School of Medicine, New Haven, CT, United States.; Barbaro M; Department of Neurology, NYU Grossman School of Medicine, New York, NY, United States; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, United States; Perlmutter Cancer Center, NYU Langone Health, United States.; Placantonakis DG; Department of Neurosurgery, NYU Grossman School of Medicine, New York, NY, United States; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, United States; Perlmutter Cancer Center, NYU Langone Health, United States; Department of Cell Biology, NYU Grossman School of Medicine, United States. Electronic address: Dimitris.Placantonakis@nyulangone.org.

Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 9433352 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2653 (Electronic) Linking ISSN: 09675868 NLM ISO Abbreviation: J Clin Neurosci Subsets: MEDLINE

Xie S; Ni J; McFaline-Figueroa JR; Wang Y; Bronson RT; Ligon KL; Wen PY; Roberts TM; Zhao JJ

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

Haydu JE; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Redd RA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA.; Lei MM; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Hochberg EP; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Barnes JA; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Armand P; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Soumerai JD; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Eichler AF; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Jacobsen ED; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Jordan JT; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Jacobson CA; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; LaCasce AS; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Arrillaga-Romany I; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; McFaline-Figueroa JR; Department of Neurology and Medicine, New York University, New York, NY.; Plotkin SR; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Takvorian RW; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Chukwueke UN; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Crombie JL; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Johnson PC; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Karschnia P; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Neurosurgery, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.; Dietrich J; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.; Nayak L; Department of Medicine, Harvard Medical School, Boston, MA.; Department of Lymphoma, Dana-Farber Brigham Cancer Center, Boston, MA.; Abramson JS; Department of Lymphoma, Mass General Cancer Center, Boston, MA.; Department of Medicine, Harvard Medical School, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Aquilanti E; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Miller JJ; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Lan Z; Harvard Medical School, Harvard University, Boston, MA, United States.; Center for Clinical Investigation, Brigham and Women's Hospital, Boston, MA, United States.; Lasica AB; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Arrillaga-Romany I; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Batchelor TT; Harvard Medical School, Harvard University, Boston, MA, United States.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States.; Berger TR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Dietrich J; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Forst DA; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Gerstner ER; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Castro LNG; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, United States.; Jordan JT; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Mcfaline-Figueroa JR; Brain & Spine Tumor Center, Perlmutter Cancer Center, NYU Langone Health, New York, NY, United States.; Department of Neurology, Grossman School of Medicine, New York University, New York, NY, United States.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Nakhate V; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Ospina JP; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Plotkin SR; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Wang N; Harvard Medical School, Harvard University, Boston, MA, United States.; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, United States.; Rhee JY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Division of Adult Palliative Care, Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Harvard Medical School, Harvard University, Boston, MA, United States.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Nakhate V; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Westergaard C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Lan Z; Harvard Medical School, Boston.; Center for Clinical Investigation, Brigham and Women's Hospital, Boston.; Lasica AB; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Muzikansky A; Biostatistics Center, Massachusetts General Hospital, Boston.; Barlow B; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Russ A; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Aker L; Harvard Medical School, Boston.; Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston.; Jiao A; Harvard Medical School, Boston.; Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston.; Pan I; Harvard Medical School, Boston.; Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston.; Nelson TA; Division of Neuro-Oncology, Department of Neurosurgery, University of California San Francisco, San Francisco.; Nwagwu CD; Harvard Medical School, Boston.; Department of Neurosurgery, Brigham and Women's Hospital, Boston.; Aquilanti E; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Batchelor TT; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Department of Neurology, Brigham and Women's Hospital, Boston.; Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Berger TR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Castro LNG; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Department of Neurology, Brigham and Women's Hospital, Boston.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Mcfaline-Figueroa JR; Brain & Spine Tumor Center, Perlmutter Cancer Center, NYU Langone Health, New York.; Department of Neurology and Medicine, Grossman School of Medicine, New York University, New York.; Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Rhee JY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Huang RY; Harvard Medical School, Boston.; Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.; Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston.; Harvard Medical School, Boston.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

Lasica AB; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lan Z; Center for Clinical Investigation, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Miller JJ; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Jiao A; Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.; Pan I; Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.; Aker L; Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.; Prabhakar P; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Japo J; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Russ A; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Westergaard C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Aquilanti E; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Chukwueke U; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Gonzalez Castro LN; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; McFaline Figueroa JR; Department of Neurology, Grossman School of Medicine, New York University, New York, NY, USA.; Brain & Spine Tumor Center, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Lee EQ; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Nayak L; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Beroukhim R; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Batchelor TT; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Cahill DP; Department of Neurosurgery, Mass General Brigham, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Nakhate V; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lanman T; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Pablo Ospina J; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Stec N; Pappas Center for Neuro-Oncology, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Patel RV; Department of Neurosurgery, Mass General Brigham, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Meredith DM; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Bi WL; Department of Neurosurgery, Mass General Brigham, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Reardon DA; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ligon KL; Division of Neuropathology, Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Huang RY; Division of Neuroradiology, Department of Radiology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Harvard University, Boston, MA, USA.; Wen PY; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Youssef G; Harvard Medical School, Harvard University, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Brain & Spine Tumor Center, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Sun L; Department of Neurosurgery, University of California Los Angeles, Los Angeles, CA, USA.; Youssef GC; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Huang R; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Li G; Department of Biostatistics, Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.; Kim J; Department of Biostatistics, Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Batchelor TT; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Everson RG; Department of Neurosurgery, University of California Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA.; Doherty L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Stefanik J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Partridge K; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Spearman A; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Myers A; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Westergaard C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Russ A; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lavallee M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Smokovich A; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; LaForest-Roys C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Garcia Fox R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; McCluskey C; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Arnaout O; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Peruzzi P; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Cosgrove GR; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Ligon KL; Division of Neuropathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Arrillaga-Romany I; Division of Neuro-Oncology, Mass General Cancer Center, Harvard Medical School, Boston, MA, USA.; Clarke JL; Departments of Neurology and Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cloughesy TF; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA.; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Prins RM; Department of Neurosurgery, University of California Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA.; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Patrick_Wen@dfci.harvard.edu.; Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. Patrick_Wen@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Mehari M; Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.; Sibih Y; Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.; Dada A; Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.; Chang SM; Division of Neuro-Oncology, University of California San Francisco and Weill Institute for Neurosciences, San Francisco, California, USA.; Wen PY; Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Molinaro AM; Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.; Chukwueke UN; Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Budhu JA; Department of Neurology, Memorial Sloan Kettering Cancer Center, Department of Neurology, Weill Cornell Medicine, Joan & Sanford I. Weill Medical College of Cornell University, New York, New York, USA.; Jackson S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; McFaline-Figueroa JR; Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Porter A; Division of Neuro-Oncology, Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.; Hervey-Jumper SL; Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Budhu JA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Neurology, Weill Cornell Medicine, Joan & Sanford I. Weill Medical College of Cornell University, New York, New York, USA.; Chukwueke UN; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Jackson S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Lee EQ; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; McFaline-Figueroa JR; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Willmarth N; American Brain Tumor Association, Chicago, Illinois, USA.; Dalmage M; Division of Biological Sciences, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.; Kawachi I; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Arons D; National Brain Tumor Society, Newton, Massachusetts, USA.; Chang SM; Division of Neuro-Oncology, University of California San Francisco and Weill Institute for Neurosciences, San Francisco, California, USA.; Galanis E; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Hervey-Jumper SL; Department of Neurological Surgery, University of California San Francisco and Weill Institute for Neurosciences, San Francisco, California, USA.; Wen PY; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Porter AB; Department of Neurology, Mayo Clinic Cancer Center, Phoenix, Arizona, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Giglio RM; Department of Molecular Pharmacology and Therapeutics, Columbia University Medical Center, New York, NY 10032, USA.; Hou N; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Wyatt A; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Hong J; Department of Computer Science, Columbia University, New York, NY 10027, USA.; Shi L; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Vaikunthan M; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Fuchs H; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Nima JP; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Malinowski SW; Department of Oncologic Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ligon KL; Department of Oncologic Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Yosef N; Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, CA 94720, USA.; Center for Computational Biology, University of California, Berkeley, Berkeley, CA 94720, USA.; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.; Azizi E; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Department of Computer Science, Columbia University, New York, NY 10027, USA.; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.; Data Science Institute, Columbia University, New York, NY 10027, USA.; McFaline-Figueroa JL; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Heo J; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Schifino AG; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Department of Kinesiology, University of Georgia, Athens, GA, USA.; McFaline-Figueroa J; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Miller DL; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Hoffman JR; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Noble EE; Department of Nutritional Science, University of Georgia, Athens, GA, USA.; Greising SM; School of Kinesiology, University of Minnesota, Minneapolis, MN, USA.; Call JA; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.

Publisher: John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders Country of Publication: Germany NLM ID: 101552883 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-6009 (Electronic) Linking ISSN: 21905991 NLM ISO Abbreviation: J Cachexia Sarcopenia Muscle Subsets: MEDLINE

Deng D; Massachusetts Institute of Technology, Harvard University, Boston, Massachusetts, USA.; Hammoudeh L; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA.; Youssef G; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Chen YH; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts¸USA.; Shin KY; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; McFaline-Figueroa JR; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Chukwueke UN; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Tanguturi S; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Reardon DA; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Lee EQ; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Nayak L; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Arnaout O; Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Ligon KL; Department of Pathology, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Wen PY; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Rahman R; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

McFaline-Figueroa JR; Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Boston, USA.; Harvard Medical School, Boston, USA.; Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Boston, USA.; Harvard Medical School, Boston, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE; PubMed not MEDLINE

Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; Youssef GC; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.; Iorgulescu JB; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Whorral S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Allen M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Rahman R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Batchelor TT; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Arnaout O; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Peruzzi PP; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Meredith D; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Santagata S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Ligon KL; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Garcia Fox R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Chukwueke UN; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Sannes T; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Miran D; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Chiu D; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Bagley C; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Holmes EG; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Peirce B; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Youssef G; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; McFaline-Figueroa JR; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Aquilanti E; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Quant Lee E; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Nayak L; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Wen PY; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Gonzalez Castro LN; Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101640528 Publication Model: eCollection Cited Medium: Print ISSN: 2054-2577 (Print) Linking ISSN: 20542577 NLM ISO Abbreviation: Neurooncol Pract Subsets: PubMed not MEDLINE

Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; Iorgulescu JB; Molecular Diagnostics Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rahman R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Bhave V; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Muzikansky A; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Woodward E; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Whorral S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Allen M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.; Li X; Shandong University, Jinan, China.; Xy G; Shandong University, Jinan, China.; Patel J; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.; Gerstner ER; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.; Kalpathy-Cramer J; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.; Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Huang RY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Ligon KL; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9509333 Publication Model: Print Cited Medium: Internet ISSN: 1538-6899 (Electronic) Linking ISSN: 10802371 NLM ISO Abbreviation: Continuum (Minneap Minn) Subsets: MEDLINE

Rahman R; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Trippa L; Dana-Farber Cancer Institute, Boston, MA.; Lee EQ; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Arrillaga-Romany I; Massachusetts General Hospital, Boston, MA.; Fell G; Dana-Farber Cancer Institute, Boston, MA.; Touat M; Brigham and Women's Hospital, Boston, MA.; Sorbonne Universite, Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France.; McCluskey C; Dana-Farber Cancer Institute, Boston, MA.; Wiley J; Dana-Farber Cancer Institute, Boston, MA.; Gaffey S; Dana-Farber Cancer Institute, Boston, MA.; Drappatz J; University of Pittsburgh, Pittsburgh, PA.; Welch MR; Division of Neuro-Oncology, Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian, New York, NY.; Galanis E; Mayo Clinic, Rochester, MN.; Ahluwalia MS; Miami Cancer Institute, Miami, FL.; Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.; Nabors LB; University of Alabama at Birmingham, Birmingham, AL.; Hepel J; Rhode Island Hospital, Providence, RI.; Elinzano H; Rhode Island Hospital, Providence, RI.; Schiff D; University of Virginia, Charlottesville, VA.; Chukwueke UN; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Beroukhim R; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Nayak L; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; McFaline-Figueroa JR; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Batchelor TT; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Rinne ML; Dana-Farber Cancer Institute, Boston, MA.; Kaley TJ; Memorial Sloan Kettering Cancer Center, New York, NY.; Lu-Emerson C; Maine Medical Center, Portland, ME.; Mellinghoff IK; Memorial Sloan Kettering Cancer Center, New York, NY.; Bi WL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Arnaout O; Brigham and Women's Hospital, Boston, MA.; Peruzzi PP; Brigham and Women's Hospital, Boston, MA.; Haas-Kogan D; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Tanguturi S; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Cagney D; Mater Private, Dublin, Ireland.; Aizer A; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Doherty L; Dana-Farber Cancer Institute, Boston, MA.; Lavallee M; Dana-Farber Cancer Institute, Boston, MA.; Fisher-Longden B; Dana-Farber Cancer Institute, Boston, MA.; Dowling S; Dana-Farber Cancer Institute, Boston, MA.; Geduldig J; Dana-Farber Cancer Institute, Boston, MA.; Watkinson F; Dana-Farber Cancer Institute, Boston, MA.; Pisano W; Dana-Farber Cancer Institute, Boston, MA.; Malinowski S; Dana-Farber Cancer Institute, Boston, MA.; Ramkissoon S; Dana-Farber Cancer Institute, Boston, MA.; Santagata S; Brigham and Women's Hospital, Boston, MA.; Meredith DM; Brigham and Women's Hospital, Boston, MA.; Chiocca EA; Brigham and Women's Hospital, Boston, MA.; Reardon DA; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Alexander BM; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Ligon KL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Wen PY; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Christ SM; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.; Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tanguturi SK; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; Cagney D; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; Shi D; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hertler C; Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland.; Andratschke N; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.; Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Haas-Kogan D; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; Guckenberger M; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rahman R; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.

Publisher: Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology Country of Publication: Ireland NLM ID: 101713416 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6308 (Electronic) Linking ISSN: 24056308 NLM ISO Abbreviation: Clin Transl Radiat Oncol Subsets: PubMed not MEDLINE